These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8679968)

  • 21. Liposomal daunorubicin marketed for HIV-related Kaposi's sarcoma.
    Am J Health Syst Pharm; 1996 Jul; 53(13):1500, 1505. PubMed ID: 8809269
    [No Abstract]   [Full Text] [Related]  

  • 22. Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma.
    Northfelt DW; Martin FJ; Working P; Volberding PA; Russell J; Newman M; Amantea MA; Kaplan LD
    J Clin Pharmacol; 1996 Jan; 36(1):55-63. PubMed ID: 8932544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liposomal doxorubicin for treatment of AIDS-related Kaposi's sarcoma.
    Simpson JK; Miller RF; Spittle MF
    Clin Oncol (R Coll Radiol); 1993; 5(6):372-4. PubMed ID: 8305358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic toxicity of liposomal encapsulated doxorubicin.
    Coker RJ; James ND; Stewart JS
    Lancet; 1993 Mar; 341(8847):756. PubMed ID: 8095649
    [No Abstract]   [Full Text] [Related]  

  • 25. Fatal hepatic failure with liposomal doxorubicin.
    Hengge UR; Brockmeyer NH; Rasshofer R; Goos M
    Lancet; 1993 Feb; 341(8841):383-4. PubMed ID: 8094161
    [No Abstract]   [Full Text] [Related]  

  • 26. Cost-effectiveness analysis comparing liposomal anthracyclines in the treatment of AIDS-related Kaposi's sarcoma.
    Bennett CL; Golub RM; Stinson TJ; Aboulafia DM; von Roenn J; Bogner J; Goebel FD; Stewart S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):460-5. PubMed ID: 9715842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liposomal doxorubicin in AIDS-related Kaposi's sarcoma.
    Hengge UR; Brockmeyer NH; Baumann M; Reimann G; Goos M
    Lancet; 1993 Aug; 342(8869):497. PubMed ID: 8102452
    [No Abstract]   [Full Text] [Related]  

  • 28. New treatment for KS offers options for therapy.
    AIDS Alert; 1996 Feb; 11(2):21-2. PubMed ID: 11363236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi's sarcoma in AIDS.
    James ND; Coker RJ; Tomlinson D; Harris JR; Gompels M; Pinching AJ; Stewart JS
    Clin Oncol (R Coll Radiol); 1994; 6(5):294-6. PubMed ID: 7530036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kaposi's sarcoma: DaunoXome approved.
    AIDS Treat News; 1996 May; (no 246):3-4. PubMed ID: 11363485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complete remission of a case of classical Kaposi's sarcoma with liposomal doxorubicin and radiotherapy.
    Ezquerra GM; Redonnet MS; Cuchillero RO; Millet PU
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):901-2. PubMed ID: 16898935
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. The International SL-DOX Study Group.
    Goebel FD; Goldstein D; Goos M; Jablonowski H; Stewart JS
    Br J Cancer; 1996 Apr; 73(8):989-94. PubMed ID: 8611437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psoriasiform pustular eruptions from pegylated-liposomal doxorubicin in AIDS-related Kaposi's sarcoma.
    Kreuter A; Gambichler T; Schlottmann R; Altmeyer P; Brockmeyer N
    Acta Derm Venereol; 2001; 81(3):224. PubMed ID: 11558892
    [No Abstract]   [Full Text] [Related]  

  • 34. Paclitaxel for treating KS.
    Proj Inf Perspect; 1997 Nov; (23):15. PubMed ID: 11365372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin.
    Berry G; Billingham M; Alderman E; Richardson P; Torti F; Lum B; Patek A; Martin FJ
    Ann Oncol; 1998 Jul; 9(7):711-6. PubMed ID: 9739435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liposomal encapsulated anthracyclines: new therapeutic horizons.
    Muggia FM
    Curr Oncol Rep; 2001 Mar; 3(2):156-62. PubMed ID: 11177748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liposomal doxorubicin in the treatment of advanced AIDS-related Kaposi sarcoma.
    Bogner JR; Kronawitter U; Rolinski B; Truebenbach K; Goebel FD
    J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):463-8. PubMed ID: 8158540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liposomal doxorubicin.
    Linsky KF; Ignoffo RJ
    Cancer Pract; 1996; 4(5):288-90. PubMed ID: 9004577
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacology of liposomal daunorubicin and its use in Kaposi's sarcoma.
    Chew T; Jacobs M
    Oncology (Williston Park); 1996 Jun; 10(6 Suppl):28-33; discussion 37-8. PubMed ID: 16871707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of liposomal anthracyclines: from basics to clinical applications.
    Gabizon A; Goren D; Cohen R; Barenholz Y
    J Control Release; 1998 Apr; 53(1-3):275-9. PubMed ID: 9741935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.